Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PIK3CA |
Variant | Q546X |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | PIK3CA Q546X indicates any PIK3CA missense mutation that results in replacement of the glutamine (Q) at amino acid 546 by a different amino acid. |
Associated Drug Resistance | |
Category Variants Paths |
PIK3CA mutant PIK3CA exon10 PIK3CA Q546X |
Transcript | NM_006218.4 |
gDNA | chr3:g.179218306_179218308 |
cDNA | c.1636_1638 |
Protein | p.Q546 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_006218.3 | chr3:g.179218306_179218308 | c.1636_1638 | p.Q546 | RefSeq | GRCh38/hg38 |
XM_011512894.2 | chr3:g.179218306_179218308 | c.1636_1638 | p.Q546 | RefSeq | GRCh38/hg38 |
XM_006713658.5 | chr3:g.179218306_179218308 | c.1636_1638 | p.Q546 | RefSeq | GRCh38/hg38 |
XM_006713658.4 | chr3:g.179218306_179218308 | c.1636_1638 | p.Q546 | RefSeq | GRCh38/hg38 |
NM_006218.4 | chr3:g.179218306_179218308 | c.1636_1638 | p.Q546 | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05154487 | Phase II | Alpelisib + Fulvestrant | A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer | Recruiting | USA | 0 |